Friday, October 5, 2012

Aspirin may 'slow elderly brain decline', study finds - BBC News

BBC NewsAspirin may 'slow elderly brain decline', study findsBBC NewsBy Anna-Marie Lever Health reporter, BBC News An aspirin a day may slow brain decline in elderly women at high risk of cardiovascular disease, research finds. Around 500 at risk women, between the ages of 70 to 92, were tracked for five years - their ...Aspirin: Protects Brain as Well as HeartMedPage TodayAspirin May Slow Brain Decline In Elderly Women With Heart RiskMedical News TodayAspirin May Help Preserve Brain

Read more ...

Thursday, October 4, 2012

Fungal meningitis death toll may rise - NBCNews.com (blog)

San Francisco ChronicleFungal meningitis death toll may riseNBCNews.com (blog)By Maggie Fox, NBC News Health officials have traced an outbreak of meningitis to a Massachusetts specialty pharmacy that makes the steroid they believe is contaminated with a fungus. So far, 26 people have been diagnosed with the rare type of fungal ...More Meningitis Cases Will Develop, Says TN Health CommissionerPatch.comRare US meningitis outbreak grows, 4 dead, 22 sickCTV NewsIn Outbreak, Meningitis Is Reported

Read more ...

Wednesday, October 3, 2012

Vitamin D No Match for Common Cold - MedPage Today

IBNLiveVitamin D No Match for Common ColdMedPage TodayBy Crystal Phend, Senior Staff Writer, MedPage Today Vitamin D supplements don't prevent colds or ease their severity in adults without deficiency, a study has found. Note that missed workdays and duration of symptoms likewise were similar between ...Trying to Avoid a Cold? Skip the Vitamin D SupplementsTIME'No proof' vitamin D stops coldsBBC NewsVitamin D supplements don't fend off colds, new study

Read more ...

Tuesday, October 2, 2012

Foundation Slams Romney Health Proposals - MedPage Today

PoliticoFoundation Slams Romney Health ProposalsMedPage TodayBy David Pittman, Washington Correspondent, MedPage Today WASHINGTON -- A report released on the eve of the first presidential debate paints a stark contrast between President Obama's and Mitt Romney's healthcare policies and their potential impact on ...New report compares Obama, Romney health care plansCNN (blog)Analysis: Romney would send consumers healthcare bill, with benefitsReutersContinuing the campus health care

Read more ...

Foundation Slams Romney Health Proposals - MedPage Today

PoliticoFoundation Slams Romney Health ProposalsMedPage TodayBy David Pittman, Washington Correspondent, MedPage Today WASHINGTON -- A report released on the eve of the first presidential debate paints a stark contrast between President Obama's and Mitt Romney's healthcare policies and their potential impact on ...New report compares Obama, Romney health care plansCNN (blog)Continuing the campus health care conversationThe University of Alabama Crimson WhiteElections 2012: Denver Debate

Read more ...

Monday, October 1, 2012

One Year On Herceptin For Breast Cancer Ideal - Medical News Today

Moneycontrol.comOne Year On Herceptin For Breast Cancer IdealMedical News TodayPatients in early-stage HER2-positive breast cancer should remain on Herceptin (trastuzumab) treatment for one year, and not two years or six months, according to a final analysis of the Phase III HERA trial, pharmaceutical company Roche and the Breast ...Herceptin data fends off $ 1.5B threat to Roche salesFiercePharmaCurrent Length of Herceptin Cancer Treatment Is Supported by StudiesNew York TimesCancer trials

Read more ...

Current Length of Herceptin Cancer Treatment Is Supported by Studies - New York Times

Moneycontrol.comCurrent Length of Herceptin Cancer Treatment Is Supported by StudiesNew York TimesEven as Herceptin has become a hugely successful breast cancer drug, doctors have been troubled by a nagging question that has billion-dollar implications: how long should patients be treated with it? Now the results of two closely watched studies ...Cancer trials show one year on Roche's Herceptin is bestReutersNew findings on optimal duration of trastuzumab therapy for women with HER2+

Read more ...